Loading…

5PSQ-006 Parenteral nutrition in a neonatology intensive care unit: duration and complications

Background and importanceParenteral nutrition (PN) can be used in any malnourished child or anyone at risk of malnutrition. In preterm newborns, it should be started in the first hours of life, although this artificial technique is not exempt from a series of complications related to its use.Aim and...

Full description

Saved in:
Bibliographic Details
Published in:European journal of hospital pharmacy. Science and practice 2020-03, Vol.27 (Suppl 1), p.A152-A152
Main Authors: Álvarez Asteinza, C, Gómez Álvarez, ME, Arias Martínez, A, Menárguez Blanc, R, López, Á Pieras, Zarate Tamames, B, Maray Mateos, I, Macía Rivas, MD, Fernández Laguna, CL, Lozano Blázquez, A
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page A152
container_issue Suppl 1
container_start_page A152
container_title European journal of hospital pharmacy. Science and practice
container_volume 27
creator Álvarez Asteinza, C
Gómez Álvarez, ME
Arias Martínez, A
Menárguez Blanc, R
López, Á Pieras
Zarate Tamames, B
Maray Mateos, I
Macía Rivas, MD
Fernández Laguna, CL
Lozano Blázquez, A
description Background and importanceParenteral nutrition (PN) can be used in any malnourished child or anyone at risk of malnutrition. In preterm newborns, it should be started in the first hours of life, although this artificial technique is not exempt from a series of complications related to its use.Aim and objectivesTo analyse the use, prescription time and incidence of complications of PN in a neonatology intensive care unit (ICU).Material and methodsA retrospective descriptive study on the use of PN in the neonatology ICU in our hospital was performed in 2018. Demographic data, birth weight, prescription/reason for suspension, total number of PNs developed, type of nutrition, number of prescription days, metabolic complications (MC) (out of range glucose and triglyceride levels) and electrolytic complications (EC) (out of range ions) were collected from the electronic medical records and PN software.ResultsSixty-one patients (56% male, 44% female) were included in the study: 497 PN were prescribed, all central, and motivated by prematurity (97%), sepsis (1.5%) and oesophageal atresia (1.5%). Causes of cessation were transition to venoclysis (79%), oral nutrition via a nasogastric tube (8%), enteral nutrition via a nasogastric tube (6.5%), death (5%) or loss of central venous line (1.5%).The number of days PN was given was 15 (n=7). Mean duration in preterm infants by weight was 9.5 days (≤1.5 kg, n=31) and 8 days (>1.5 kg, n=28).Out of range analytical determinations were observed in 116 cases. The average altered parameters in premature infants according to weight were: 2 (≤1.5 kg) and 0.9 (>1.5 kg). The average alterations according to duration were: 0.5 (≤5 days), 1.5 (5–10 days) and 3 (>10 days).Alterations were detected in 41 patients (67%); 65.5% only developed EC and 36% only MC. The most frequent were hypernatraemia (31%) in EC and hyperglycaemia (24.5%) in MC (also being the earliest).Conclusion and relevanceThe main reason for prescription of PN in neonates was prematurity. The main reason for cessation was a switch to venoclysis. Usage time was slightly longer in those with a lower birth weight. For alterations, the most frequent was hypernatraemia and the earliest hyperglycaemia.References and/or acknowledgementsNo conflict of interest.
doi_str_mv 10.1136/ejhpharm-2020-eahpconf.323
format article
fullrecord <record><control><sourceid>proquest_bmj_p</sourceid><recordid>TN_cdi_proquest_journals_2382938551</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2382938551</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1263-a0f6f06ac165d4052ce9536c8df96566c4ad22096685064efdacf6c13d864a2f3</originalsourceid><addsrcrecordid>eNo9kM1KAzEUhYMoWGrfIeh6an4m14k7Kf5BQUVdxzST2JSZZMzMCN258UV9EqetdXUuh4974EPolJIppRzO7WrZLHWqM0YYyaxeNiYGN-WMH6ARI_lFJiXkh_-3gGM0aVu_IILzQuZcjtCbeHx-ygiBn6_vR51s6GzSFQ59l3znY8A-YI2DjUF3sYrv66HobGj9p8Vm4HEffHeJyz7pLa5DiU2sm8qbbdGeoCOnq9ZO_nKMXm-uX2Z32fzh9n52Nc8WlAHPNHHgCGhDQZQ5EcxYKTiYonQSBIDJdckYkQCFIJBbV2rjwFBeFpBr5vgYne3-Nil-9Lbt1Cr2KQyTivGCSV4IQQdK7KhFvVJN8rVOa0WJ2vhUe59q41PtfarBJ_8FkdRvgg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2382938551</pqid></control><display><type>article</type><title>5PSQ-006 Parenteral nutrition in a neonatology intensive care unit: duration and complications</title><source>PubMed Central</source><creator>Álvarez Asteinza, C ; Gómez Álvarez, ME ; Arias Martínez, A ; Menárguez Blanc, R ; López, Á Pieras ; Zarate Tamames, B ; Maray Mateos, I ; Macía Rivas, MD ; Fernández Laguna, CL ; Lozano Blázquez, A</creator><creatorcontrib>Álvarez Asteinza, C ; Gómez Álvarez, ME ; Arias Martínez, A ; Menárguez Blanc, R ; López, Á Pieras ; Zarate Tamames, B ; Maray Mateos, I ; Macía Rivas, MD ; Fernández Laguna, CL ; Lozano Blázquez, A</creatorcontrib><description>Background and importanceParenteral nutrition (PN) can be used in any malnourished child or anyone at risk of malnutrition. In preterm newborns, it should be started in the first hours of life, although this artificial technique is not exempt from a series of complications related to its use.Aim and objectivesTo analyse the use, prescription time and incidence of complications of PN in a neonatology intensive care unit (ICU).Material and methodsA retrospective descriptive study on the use of PN in the neonatology ICU in our hospital was performed in 2018. Demographic data, birth weight, prescription/reason for suspension, total number of PNs developed, type of nutrition, number of prescription days, metabolic complications (MC) (out of range glucose and triglyceride levels) and electrolytic complications (EC) (out of range ions) were collected from the electronic medical records and PN software.ResultsSixty-one patients (56% male, 44% female) were included in the study: 497 PN were prescribed, all central, and motivated by prematurity (97%), sepsis (1.5%) and oesophageal atresia (1.5%). Causes of cessation were transition to venoclysis (79%), oral nutrition via a nasogastric tube (8%), enteral nutrition via a nasogastric tube (6.5%), death (5%) or loss of central venous line (1.5%).The number of days PN was given was &lt;3 (n=7), 4–7 (n=21), 8–11 (n=18), 12–15 (n=8) and &gt;15 (n=7). Mean duration in preterm infants by weight was 9.5 days (≤1.5 kg, n=31) and 8 days (&gt;1.5 kg, n=28).Out of range analytical determinations were observed in 116 cases. The average altered parameters in premature infants according to weight were: 2 (≤1.5 kg) and 0.9 (&gt;1.5 kg). The average alterations according to duration were: 0.5 (≤5 days), 1.5 (5–10 days) and 3 (&gt;10 days).Alterations were detected in 41 patients (67%); 65.5% only developed EC and 36% only MC. The most frequent were hypernatraemia (31%) in EC and hyperglycaemia (24.5%) in MC (also being the earliest).Conclusion and relevanceThe main reason for prescription of PN in neonates was prematurity. The main reason for cessation was a switch to venoclysis. Usage time was slightly longer in those with a lower birth weight. For alterations, the most frequent was hypernatraemia and the earliest hyperglycaemia.References and/or acknowledgementsNo conflict of interest.</description><identifier>ISSN: 2047-9956</identifier><identifier>EISSN: 2047-9964</identifier><identifier>DOI: 10.1136/ejhpharm-2020-eahpconf.323</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Birth weight ; Hyperglycemia ; Intensive care ; Nutrition ; Parenteral nutrition</subject><ispartof>European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A152-A152</ispartof><rights>Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Álvarez Asteinza, C</creatorcontrib><creatorcontrib>Gómez Álvarez, ME</creatorcontrib><creatorcontrib>Arias Martínez, A</creatorcontrib><creatorcontrib>Menárguez Blanc, R</creatorcontrib><creatorcontrib>López, Á Pieras</creatorcontrib><creatorcontrib>Zarate Tamames, B</creatorcontrib><creatorcontrib>Maray Mateos, I</creatorcontrib><creatorcontrib>Macía Rivas, MD</creatorcontrib><creatorcontrib>Fernández Laguna, CL</creatorcontrib><creatorcontrib>Lozano Blázquez, A</creatorcontrib><title>5PSQ-006 Parenteral nutrition in a neonatology intensive care unit: duration and complications</title><title>European journal of hospital pharmacy. Science and practice</title><description>Background and importanceParenteral nutrition (PN) can be used in any malnourished child or anyone at risk of malnutrition. In preterm newborns, it should be started in the first hours of life, although this artificial technique is not exempt from a series of complications related to its use.Aim and objectivesTo analyse the use, prescription time and incidence of complications of PN in a neonatology intensive care unit (ICU).Material and methodsA retrospective descriptive study on the use of PN in the neonatology ICU in our hospital was performed in 2018. Demographic data, birth weight, prescription/reason for suspension, total number of PNs developed, type of nutrition, number of prescription days, metabolic complications (MC) (out of range glucose and triglyceride levels) and electrolytic complications (EC) (out of range ions) were collected from the electronic medical records and PN software.ResultsSixty-one patients (56% male, 44% female) were included in the study: 497 PN were prescribed, all central, and motivated by prematurity (97%), sepsis (1.5%) and oesophageal atresia (1.5%). Causes of cessation were transition to venoclysis (79%), oral nutrition via a nasogastric tube (8%), enteral nutrition via a nasogastric tube (6.5%), death (5%) or loss of central venous line (1.5%).The number of days PN was given was &lt;3 (n=7), 4–7 (n=21), 8–11 (n=18), 12–15 (n=8) and &gt;15 (n=7). Mean duration in preterm infants by weight was 9.5 days (≤1.5 kg, n=31) and 8 days (&gt;1.5 kg, n=28).Out of range analytical determinations were observed in 116 cases. The average altered parameters in premature infants according to weight were: 2 (≤1.5 kg) and 0.9 (&gt;1.5 kg). The average alterations according to duration were: 0.5 (≤5 days), 1.5 (5–10 days) and 3 (&gt;10 days).Alterations were detected in 41 patients (67%); 65.5% only developed EC and 36% only MC. The most frequent were hypernatraemia (31%) in EC and hyperglycaemia (24.5%) in MC (also being the earliest).Conclusion and relevanceThe main reason for prescription of PN in neonates was prematurity. The main reason for cessation was a switch to venoclysis. Usage time was slightly longer in those with a lower birth weight. For alterations, the most frequent was hypernatraemia and the earliest hyperglycaemia.References and/or acknowledgementsNo conflict of interest.</description><subject>Birth weight</subject><subject>Hyperglycemia</subject><subject>Intensive care</subject><subject>Nutrition</subject><subject>Parenteral nutrition</subject><issn>2047-9956</issn><issn>2047-9964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo9kM1KAzEUhYMoWGrfIeh6an4m14k7Kf5BQUVdxzST2JSZZMzMCN258UV9EqetdXUuh4974EPolJIppRzO7WrZLHWqM0YYyaxeNiYGN-WMH6ARI_lFJiXkh_-3gGM0aVu_IILzQuZcjtCbeHx-ygiBn6_vR51s6GzSFQ59l3znY8A-YI2DjUF3sYrv66HobGj9p8Vm4HEffHeJyz7pLa5DiU2sm8qbbdGeoCOnq9ZO_nKMXm-uX2Z32fzh9n52Nc8WlAHPNHHgCGhDQZQ5EcxYKTiYonQSBIDJdckYkQCFIJBbV2rjwFBeFpBr5vgYne3-Nil-9Lbt1Cr2KQyTivGCSV4IQQdK7KhFvVJN8rVOa0WJ2vhUe59q41PtfarBJ_8FkdRvgg</recordid><startdate>202003</startdate><enddate>202003</enddate><creator>Álvarez Asteinza, C</creator><creator>Gómez Álvarez, ME</creator><creator>Arias Martínez, A</creator><creator>Menárguez Blanc, R</creator><creator>López, Á Pieras</creator><creator>Zarate Tamames, B</creator><creator>Maray Mateos, I</creator><creator>Macía Rivas, MD</creator><creator>Fernández Laguna, CL</creator><creator>Lozano Blázquez, A</creator><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>202003</creationdate><title>5PSQ-006 Parenteral nutrition in a neonatology intensive care unit: duration and complications</title><author>Álvarez Asteinza, C ; Gómez Álvarez, ME ; Arias Martínez, A ; Menárguez Blanc, R ; López, Á Pieras ; Zarate Tamames, B ; Maray Mateos, I ; Macía Rivas, MD ; Fernández Laguna, CL ; Lozano Blázquez, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1263-a0f6f06ac165d4052ce9536c8df96566c4ad22096685064efdacf6c13d864a2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Birth weight</topic><topic>Hyperglycemia</topic><topic>Intensive care</topic><topic>Nutrition</topic><topic>Parenteral nutrition</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Álvarez Asteinza, C</creatorcontrib><creatorcontrib>Gómez Álvarez, ME</creatorcontrib><creatorcontrib>Arias Martínez, A</creatorcontrib><creatorcontrib>Menárguez Blanc, R</creatorcontrib><creatorcontrib>López, Á Pieras</creatorcontrib><creatorcontrib>Zarate Tamames, B</creatorcontrib><creatorcontrib>Maray Mateos, I</creatorcontrib><creatorcontrib>Macía Rivas, MD</creatorcontrib><creatorcontrib>Fernández Laguna, CL</creatorcontrib><creatorcontrib>Lozano Blázquez, A</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>European journal of hospital pharmacy. Science and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Álvarez Asteinza, C</au><au>Gómez Álvarez, ME</au><au>Arias Martínez, A</au><au>Menárguez Blanc, R</au><au>López, Á Pieras</au><au>Zarate Tamames, B</au><au>Maray Mateos, I</au><au>Macía Rivas, MD</au><au>Fernández Laguna, CL</au><au>Lozano Blázquez, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>5PSQ-006 Parenteral nutrition in a neonatology intensive care unit: duration and complications</atitle><jtitle>European journal of hospital pharmacy. Science and practice</jtitle><date>2020-03</date><risdate>2020</risdate><volume>27</volume><issue>Suppl 1</issue><spage>A152</spage><epage>A152</epage><pages>A152-A152</pages><issn>2047-9956</issn><eissn>2047-9964</eissn><abstract>Background and importanceParenteral nutrition (PN) can be used in any malnourished child or anyone at risk of malnutrition. In preterm newborns, it should be started in the first hours of life, although this artificial technique is not exempt from a series of complications related to its use.Aim and objectivesTo analyse the use, prescription time and incidence of complications of PN in a neonatology intensive care unit (ICU).Material and methodsA retrospective descriptive study on the use of PN in the neonatology ICU in our hospital was performed in 2018. Demographic data, birth weight, prescription/reason for suspension, total number of PNs developed, type of nutrition, number of prescription days, metabolic complications (MC) (out of range glucose and triglyceride levels) and electrolytic complications (EC) (out of range ions) were collected from the electronic medical records and PN software.ResultsSixty-one patients (56% male, 44% female) were included in the study: 497 PN were prescribed, all central, and motivated by prematurity (97%), sepsis (1.5%) and oesophageal atresia (1.5%). Causes of cessation were transition to venoclysis (79%), oral nutrition via a nasogastric tube (8%), enteral nutrition via a nasogastric tube (6.5%), death (5%) or loss of central venous line (1.5%).The number of days PN was given was &lt;3 (n=7), 4–7 (n=21), 8–11 (n=18), 12–15 (n=8) and &gt;15 (n=7). Mean duration in preterm infants by weight was 9.5 days (≤1.5 kg, n=31) and 8 days (&gt;1.5 kg, n=28).Out of range analytical determinations were observed in 116 cases. The average altered parameters in premature infants according to weight were: 2 (≤1.5 kg) and 0.9 (&gt;1.5 kg). The average alterations according to duration were: 0.5 (≤5 days), 1.5 (5–10 days) and 3 (&gt;10 days).Alterations were detected in 41 patients (67%); 65.5% only developed EC and 36% only MC. The most frequent were hypernatraemia (31%) in EC and hyperglycaemia (24.5%) in MC (also being the earliest).Conclusion and relevanceThe main reason for prescription of PN in neonates was prematurity. The main reason for cessation was a switch to venoclysis. Usage time was slightly longer in those with a lower birth weight. For alterations, the most frequent was hypernatraemia and the earliest hyperglycaemia.References and/or acknowledgementsNo conflict of interest.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/ejhpharm-2020-eahpconf.323</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2047-9956
ispartof European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A152-A152
issn 2047-9956
2047-9964
language eng
recordid cdi_proquest_journals_2382938551
source PubMed Central
subjects Birth weight
Hyperglycemia
Intensive care
Nutrition
Parenteral nutrition
title 5PSQ-006 Parenteral nutrition in a neonatology intensive care unit: duration and complications
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T19%3A14%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=5PSQ-006%E2%80%85Parenteral%20nutrition%20in%20a%20neonatology%20intensive%20care%20unit:%20duration%20and%20complications&rft.jtitle=European%20journal%20of%20hospital%20pharmacy.%20Science%20and%20practice&rft.au=%C3%81lvarez%20Asteinza,%20C&rft.date=2020-03&rft.volume=27&rft.issue=Suppl%201&rft.spage=A152&rft.epage=A152&rft.pages=A152-A152&rft.issn=2047-9956&rft.eissn=2047-9964&rft_id=info:doi/10.1136/ejhpharm-2020-eahpconf.323&rft_dat=%3Cproquest_bmj_p%3E2382938551%3C/proquest_bmj_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b1263-a0f6f06ac165d4052ce9536c8df96566c4ad22096685064efdacf6c13d864a2f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2382938551&rft_id=info:pmid/&rfr_iscdi=true